Home › Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

Dec 08, 2016

NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that Aetna has agreed to cover its ThyraMir microRNA classifier test for thyroid nodules.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Aug
27
Featured Webinar

Case Study: Genetic Testing Lab Sees 25-Fold Scaleup with New Informatics System

Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

What's Popular?

In Cancer

  1. MDxHealth Hopes to Build Lead in Prostate Risk Testing With Utility Evidence for SelectMDx

    Premium

  2. China FDA Approves Novogene CDx Test for NSCLC Therapies

  3. Genetic Technologies Announces Planned Chinese Joint Venture

  4. Natera Partners With Fox Chase to Evaluate ctDNA Cancer Assay

  5. Dx Companies See Rise in Demand for Integrated Clinical Chemistry, Immunoassay Systems for Central Labs

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.